RecruitingPhase 3NCT03966014

Different Amoxicillin Treatment Regimens in Erythema Migrans Patients

Different Duration and Dosing of Amoxicillin in Patients With Erythema Migrans. A Randomized Clinical Trial.

Sponsor

University Medical Centre Ljubljana

Enrollment

200 participants

Start Date

Jun 1, 2019

Study Type

INTERVENTIONAL

Conditions

Erythema Migrans

Summary

The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Controls, a drug called EM-amoxicillin 3 x 10 days, and others for people with erythema migrans. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEM-amoxicillin 3 x 10 days

Patients will receive amoxicillin 500 milligram tid for 10 days

DRUGEM-amoxicillin 3 x 14 days

Patients will receive amoxicillin 500 milligram tid for 14 days

OTHERControls

No intervention.

Locations(2)

University Medical Centre Ljubljana

Ljubljana, Slovenia

University Medical Centre Ljubljana

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03966014

Related Trials

Patient's Pretreatment Expectations About Post-Lyme Symptoms

NCT034623291 location